Drugmaker
PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma
Novartis lifts 2020 forecast as drugmakers see hospitals coping with Covid
Covid-19 vaccine makers must deliver to US in time to get full payments
Moderna shares soar over 16% over coronavirus vaccine trial result
Drugmakers slash prices to be eligible for China's bulk-buy program

Drugmakers from Pfizer to GSK to hike US prices up to 10% on over 200 drugs
MNCs, domestic drug makers did equally well in terms of growth rate
Medicines costing less than Rs 5 per dose may be taken out of price control
Dr Reddy's Labs looks to recover from Q1 blues with multiple growth drivers
Drug companies step up global investments to tap biosimilars

Delhi High Court grants temporary relief to Abbott, Glenmark in drug ban case